# Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With Hypertension

> **NCT00672113** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 43 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Adalat (Nifedipine, BAYA1040)
- **DRUG:** Coracten

## Key facts

- **NCT ID:** NCT00672113
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2014-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00672113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00672113, "Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00672113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*